HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nicholas R Lemoine Selected Research
Nicholas R Lemoine Research Topics
Disease
42
Neoplasms (Cancer)
09/2022 - 05/2002
21
Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 05/2002
9
Adenocarcinoma
10/2018 - 09/2003
4
Ovarian Neoplasms (Ovarian Cancer)
06/2010 - 06/2003
3
Melanoma (Melanoma, Malignant)
01/2022 - 07/2003
3
Neoplasm Metastasis (Metastasis)
03/2013 - 02/2002
3
Prostatic Neoplasms (Prostate Cancer)
10/2010 - 09/2004
2
Hypoxia (Hypoxemia)
01/2018 - 03/2013
2
Carcinogenesis
09/2015 - 07/2004
2
Inborn Genetic Diseases (Disease, Hereditary)
07/2013 - 07/2012
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2009 - 11/2003
2
Pancreatic Diseases (Pancreatic Disease)
07/2008 - 11/2007
2
Chronic Pancreatitis
11/2007 - 11/2005
1
Glioma (Gliomas)
09/2022
1
Esophageal Squamous Cell Carcinoma
11/2020
1
Breast Neoplasms (Breast Cancer)
01/2020
1
Adenocarcinoma of Lung
01/2018
1
Urinary Bladder Neoplasms (Bladder Cancer)
02/2014
1
Adenoviridae Infections (Adenovirus Infections)
02/2014
1
Poxviridae Infections
03/2013
1
Communicable Diseases (Infectious Diseases)
03/2013
1
Infections
03/2013
1
Malignant Mesothelioma
06/2010
1
Colorectal Neoplasms (Colorectal Cancer)
06/2010
1
Hepatocellular Carcinoma (Hepatoma)
06/2010
1
Kidney Neoplasms (Kidney Cancer)
06/2010
Drug/Important Bio-Agent (IBA)
15
Proteins (Proteins, Gene)
FDA Link
06/2022 - 02/2002
5
Pharmaceutical Preparations
IBA
10/2010 - 10/2004
4
Biomarkers (Surrogate Marker)
IBA
02/2014 - 09/2003
4
DNA (Deoxyribonucleic Acid)
IBA
01/2009 - 05/2004
4
Complementary DNA (cDNA)
IBA
12/2005 - 05/2002
3
Immune Checkpoint Inhibitors
IBA
09/2022 - 09/2018
3
Antigens
IBA
01/2022 - 10/2004
3
Interleukin-12 (IL 12)
IBA
11/2020 - 11/2017
3
Proteome
IBA
07/2013 - 07/2008
2
Epitopes
IBA
01/2022 - 07/2003
2
Ligands
IBA
01/2022 - 09/2004
2
Transcription Factors (Transcription Factor)
IBA
01/2018 - 09/2004
2
Gemcitabine
FDA Link
01/2016 - 04/2005
2
Interleukin-10 (Interleukin 10)
IBA
09/2015 - 01/2015
2
Argininosuccinate Synthase (Argininosuccinate Synthetase)
IBA
02/2014 - 06/2010
2
Arginine (L-Arginine)
FDA Link
02/2014 - 06/2010
2
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
01/2014 - 11/2003
2
Peptide Hydrolases (Proteases)
FDA Link
11/2011 - 09/2007
2
Cathepsin D
IBA
11/2011 - 09/2007
2
Cytokines
IBA
06/2010 - 07/2004
2
Biological Products
IBA
01/2008 - 05/2004
2
Antibodies
IBA
11/2007 - 11/2005
2
Calcium-Binding Proteins
IBA
09/2007 - 10/2003
2
Androgens
IBA
12/2005 - 09/2004
2
Lipocalin-2
IBA
10/2004 - 05/2002
1
interleukin-21 (interleukin 21)
IBA
09/2022
1
Therapeutic Uses
IBA
09/2022
1
Chimeric Antigen Receptors
IBA
06/2022
1
Viral Antigens
IBA
06/2022
1
Histone Deacetylase Inhibitors
IBA
01/2022
1
Peptides (Polypeptides)
IBA
01/2022
1
HLA-A Antigens (HLA-A)
IBA
01/2022
1
Histocompatibility Antigens Class II
IBA
01/2022
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2022
1
Cisplatin (Platino)
FDA Link
Generic
11/2020
1
IC 87114
IBA
01/2020
1
idelalisib
IBA
01/2020
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
01/2020
1
Activins (Activin)
IBA
10/2018
1
Oxygen (Dioxygen)
IBA
01/2018
1
Indicators and Reagents (Reagents)
IBA
01/2018
1
Tretinoin (Retinoic Acid)
FDA Link
Generic
01/2016
1
Retinoids
IBA
01/2016
1
Folic Acid Antagonists
IBA
02/2014
1
Enzymes
IBA
02/2014
1
Chemokines
IBA
02/2014
1
Urea (Carbamide)
FDA Link
Generic
02/2014
1
Collagen
IBA
03/2013
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2013
1
Antiviral Agents (Antivirals)
IBA
12/2012
1
Neutralizing Antibodies
IBA
02/2012
1
Cathepsin B
IBA
11/2011
1
Cathepsins
IBA
11/2011
1
Proteasome Endopeptidase Complex (Proteasome)
IBA
11/2011
1
Ubiquitin
IBA
11/2011
1
Surface Antigens (Surface Antigen)
IBA
11/2011
1
MicroRNAs (MicroRNA)
IBA
01/2011
1
Mitoxantrone (Novantrone)
FDA Link
Generic
10/2010
1
Hormones (Hormone)
IBA
10/2010
1
Retinoblastoma Protein
IBA
10/2010
1
Docetaxel (Taxotere)
FDA Link
10/2010
1
dl1520 (ONYX-015)
IBA
10/2010
1
Essential Amino Acids
IBA
06/2010
1
Platinum
IBA
06/2010
1
TOR Serine-Threonine Kinases
IBA
02/2009
Therapy/Procedure
13
Therapeutics
11/2020 - 05/2004
7
Immunotherapy
06/2022 - 07/2003
4
Drug Therapy (Chemotherapy)
01/2016 - 05/2004
1
Precision Medicine
01/2020
1
Oncolytic Virotherapy
01/2020
1
Mammaplasty (Breast Reconstruction)
01/2020
1
Biological Therapy
03/2013
1
Pancreatectomy
01/2013
1
Chemoradiotherapy
01/2012